
In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.
Brigatinib: Serious and Common Side EffectsBrigatinib may cause a variety of side effects, not everyone experiences them. If the following serious reactions occur, tell your doctor···【more】
Article source:Captain MedicineRelease date:2026-05-22Recommended:273
Standard Dosage and Initial Treatment Regimen of BrigatinibBrigatinib must be taken exactly as directed by your doctor or pharmacist. The recommended dosage is given in two phases:···【more】
Article source:Captain MedicineRelease date:2026-05-22Recommended:207
Indications and Mechanism of Action of BrigatinibBrigatinib is used to treat adult patients with advanced non-small cell lung cancer, especially those whose tumors have a genetic d···【more】
Article source:Captain MedicineRelease date:2026-05-22Recommended:192
Health conditions you must tell your doctor about before using brigatinibBefore starting treatment with Alunbrig (brigatinib) and during treatment, you must contact your doctor imm···【more】
Article source:Captain MedicineRelease date:2026-05-22Recommended:198
Serious Side Effects Warnings for Brigatinib (Alunbrig)Brigatinib (Alunbrig) may cause serious side effects, and patients need to be highly vigilant. First, lung problems: Brigatin···【more】
Article source:Captain MedicineRelease date:2026-05-21Recommended:217
Brigatinib for Second-Line Treatment After Progression on CrizotinibAlthough targeted therapy has brought hope to patients with ALK-positive NSCLC, unfortunately, even after treatm···【more】
Article source:Captain MedicineRelease date:2026-05-21Recommended:206
How effective is the treatment with Brigatinib (Alunbrig)?A pivotal clinical study of brigatinib enrolled a total of 275 patients with ALK-positive NSCLC that had spread to other p···【more】
Article source:Captain MedicineRelease date:2026-05-21Recommended:186
Mechanism of Action of Brigatinib (Alunbrig)Brigatinib (Alunbrig) is an oral prescription targeted therapy drug belonging to the class of tyrosine kinase inhibitors (TKIs). It work···【more】
Article source:Captain MedicineRelease date:2026-05-21Recommended:176
Recommended Dosage and Administration of CrizotinibThe recommended dosage for adults with non-small cell lung cancer is 250 mg (one capsule) each time, taken twice daily (morning a···【more】
Article source:Captain MedicineRelease date:2026-05-20Recommended:188
Drug Interaction Risks of Crizotinib with Other MedicationsCrizotinib has many drug interactions that may increase side effects or reduce efficacy. Medications to avoid include cer···【more】
Article source:Captain MedicineRelease date:2026-05-20Recommended:199
Absolute Contraindications and Allergic Reactions to CrizotinibCrizotinib is contraindicated in the following situations: hypersensitivity to crizotinib or any other ingredients in···【more】
Article source:Captain MedicineRelease date:2026-05-20Recommended:190
Overview and Mechanism of Action of CrizotinibCrizotinib is a prescription medicine used to treat cancer, with its active ingredient being crizotinib. The drug works by inhibiting ···【more】
Article source:Captain MedicineRelease date:2026-05-20Recommended:175
On November 21, 2025, the U.S. Food and Drug Administration (FDA) approved the regimen of pembrolizu···【more】
Recommended:[list:visits]2025-17-12
Lung cancer is the most rapidly increasing malignant tumor with the fastest increasing morbidity and···【more】
Recommended:[list:visits]2024-09-07
Lucius Pharmaceuticals Version of Vibegron Now Available1.Basic Drug InformationVibegron (generic na···【more】
Recommended:[list:visits]2026-06-08
In recent years, leveraging the World Trade Organization (WTO) patent waiver for least-developed cou···【more】
Recommended:[list:visits]2026-05-08
How Can Chinese Patients Access Generic Drugs from Laos?In recent years, generic drugs from Laos hav···【more】
Recommended:[list:visits]2026-04-08
Lucius Pharmaceuticals version of Ibrutinib is now availableIn a randomized controlled trial of 269 ···【more】
Recommended:[list:visits]2026-03-08
Leveraging the WTO patent waiver for least-developed countries (extended to 2033), Laos has seen rap···【more】
Recommended:[list:visits]2026-31-07
Alectinib Has Been Launched in LaosAlectinib is an oral targeted therapeutic drug belonging to the c···【more】
Recommended:[list:visits]2026-30-07

Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address: No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com

Name: Lucius

Telegram name: Vira
No.:0085253923643
Telegram name: Vira
No.:0085253923643